Navigation Links
AIDS Sufferers Protest against Proposed Patent for Tenofovir

About 150 people which included some AIDS sufferers, held protests today against the proposed move of US biotech company to patent its anti-HIV drug, Tenofovir, in India. // The demonstrators alleged that this move could halt the local production of the generic equivalent.

The company, Gilead Sciences Inc., has applied for an Indian patent on the drug tenofovir. The drug has been available in India as the generic tenofovir disoproxil fumarate since last year.

Some demonstrators beat drums and carried placards reading ‘Patients against Patents,’ and ‘Lives before Profits.’ Some wore T-shirts with the message: ‘We are HIV positive.’

The protestors were briefly detained by the police before being allowed to go home.

According to Loon Gangte, a spokesman for the Delhi Network of Positive People. ‘For many of us living with HIV/AIDS, newer drugs like tenofovir offer a new hope of continuing treatment. With patents interfering with our lives, we have no choice but to oppose them.’

Delhi Network of Positive People, along with another anti-AIDS organization, the Indian Network for People Living With HIV/AIDS, filed an application with the New Delhi Patent Office yesterday opposing Gilead’s request.

Gilead has been offering tenofovir in treatment programmes to eligible developing countries.

The number of AIDS infected people in India is estimated to be about 5.21 million the second only to South Africa.

Medecins Sans Frontiers, an international medical aid agency providing technical support to the Indian groups in their legal battle has said that patenting in India would exclude millions of people from access to essential medicines.

According to them ‘TDF is clearly emerging as an important drug in the treatment of people living with HIV/AIDS.’

And therefore if Gilead were to be granted a patent in India for TDF, its generic production would be forced to h alt, making it more expensive and less easily available.
'"/>




Related medicine news :

1. Another ray of hope for Arthritis Sufferers
2. Do Asthma Sufferers Lack Physical Activity?
3. Asthma Sufferers Lacking Physical Activity
4. Hope for Dust Mite Allergy Sufferers
5. Promise for Soya Allergy Sufferers
6. Zambia Struggling To Identify AIDS Sufferers
7. Celiac Disease Sufferers See an End to their Misery
8. AIDS Sufferers Turn to British Doctor to Prolong their Survival
9. Exercise DVD Available For COPD Sufferers
10. Sleep Apnea Sufferers-Viagra May Make The Condition Worse
11. Allergy Sufferers Pass on Allergies to their Children
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:2/11/2016)... ... February 11, 2016 , ... From March 4 through 6, ... Annual Meeting at the Walter E. Washington Convention Center in Washington, D.C. , ... condition of hyperhidrosis (excessive sweating) and its treatment options. Specifically, the company will ...
(Date:2/11/2016)... ... February 11, 2016 , ... Husted Kicking has completed its ... on February 6th & 7th, 2016 according to kicking coach Michael Husted. , “This ... to the NFL’s combine in Indianapolis,” says Husted. “The NFL uses a third party ...
(Date:2/11/2016)... , ... February 11, 2016 , ... The book, “Computers ... IT services, what questions to ask your IT consultant before signing a contract and ... your computer network. , “With companies relying heavily on e-mail and technology, it’s more ...
(Date:2/11/2016)... AZ (PRWEB) , ... February 11, 2016 , ... As ... with support of the Million Dollar Round Table Foundation (MDRTF), has gifted $10,000 to ... according to Colleen’s Dream Foundation President Billy Cundiff. , “We are honored to support ...
(Date:2/10/2016)... ... February 10, 2016 , ... The 9th annual meeting ... Congress (WMIC), will be held in New York City, NY on September 7 ... The congress will highlight and emphasize how imaging reveals a greater understanding of ...
Breaking Medicine News(10 mins):
(Date:2/11/2016)... The primary goal of this research is ... the usage of liquid biopsy. Key information the survey ... Timeframe of liquid biopsy adoption amidst future users - ... type - Sample inflow to conduct liquid biopsy tests ... and so on. - Correlation analysis of sample type ...
(Date:2/11/2016)... Calif., Feb. 11, 2016 PRO-DEX, INC. (NasdaqCM: PDEX) ... ended December 31, 2015. The Company also filed its Quarterly ... year 2016 with the Securities and Exchange Commission today. ... 31, 2015 --> --> ... increased $2.6 million, or 95%, to $5.4 million from $2.8 ...
(Date:2/11/2016)...  Kindred Biosciences, Inc. (NASDAQ: KIN ), a ... of pets, today announced the submission to FDA of ... Application (NADA) for Zimeta™ (dipyrone injection, KIND-012).  Positive topline ... for the control of pyrexia (fever) in horses were ... --> The Chemistry, Manufacturing, and Controls ...
Breaking Medicine Technology: